Table 3.
Histological examination of sternal marrow sections from female BALB/c mice dosed with BU at 10.50 mg/kg on 8 occasions over 23 days, and sampled at 1, 19, 49, 91 and 112 days after the final BU dosea
Cellularity | Myelopolesis | Erythropoiesis | Megakaryopoiesis | Fat | ||||||
---|---|---|---|---|---|---|---|---|---|---|
Day | Control | BU | Control | BU | Control | BU | Control | BU | Control | BU |
1 | 3.0 | 0.6 | 3.0 | 0.2 | 3.0 | 0.0 | 3.0 | 0.0 | 0.0 | 4.8 |
19 | 3.0 | 1.2 | 3.0 | 1.2 | 3.0 | 0.0 | 3.0 | 0.4 | 0.2 | 4.6 |
49 | 3.0 | 2.4 | 3.0 | 2.6 | 3.0 | 0.2 | 3.0 | 1.2 | 0.2 | 1.8 |
91 | 3.0 | 2.0 | 3.0 | 2.2 | 3.0 | 1.6 | 3.0 | 1.4 | 0.2 | 2.2 |
112 | 3.0 | 2.8 | 3.0 | 3.0 | 3.0 | 1.8 | 3.0 | 1.6 | 0.4 | 2.4 |
Values are means; n = 5 for control and BU-treated mice at each point. Sections were assessed for cellularity, myelopoiesis, erythropoiesis, megakaryopoiesis and the presence of fat and graded on a 6 point scale: 0 = absent; 1 = very slight; 2 = slight; 3 = moderate; 4 = marked; 5 = very marked. Results were not analysed stastically.